Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
1.980
-0.260 (-11.61%)
Apr 29, 2026, 4:00 PM EDT - Market closed
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $22.19 million as of April 30, 2026. Its market cap has decreased by -41.70% in one year.
Market Cap
22.19M
Enterprise Value
12.15M
1-Year Change
-41.70%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $30.33M to $22.19M, a decrease of -26.82%. That is a compound annual growth rate of -5.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 22.19M | -34.51% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 24.51M |
| Marker Therapeutics | 24.18M |
| AEON Biopharma | 24.16M |
| Vistagen Therapeutics | 23.61M |
| CEL-SCI | 23.55M |
| Serina Therapeutics | 22.53M |
| Curis | 22.44M |
| Allarity Therapeutics | 21.83M |